Barclays
MSOS icon

Barclays’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Barclays’s Portfolio MSOS Stock Details MSOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$710K Sell
200,000
-522,900
-72% -$2.14M ﹤0.01% 2965
2025
Q4 		$3.41M Buy
+722,900
New +$3.22M ﹤0.01% 2519
2023
Q4 		– Sell
-3,048,000
Closed -$24.2M – 5308
2023
Q3 		$24.2M Buy
+3,048,000
New +$19.2M 0.02% 703

Other funds holding MSOS

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Barclays's MSOS Position: Q1 2026 in Review

Barclays reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 98% in Q1 2026, selling an estimated $340K and leaving 2,000 shares worth $7.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4739.

Barclays first reported a position in MSOS in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.91M in Q1 2022. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

  • Barclays held 2,000 shares of AdvisorShares Pure US Cannabis ETF worth $7.1K as of Q1 2026.
  • Barclays sold 83,005 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $340K.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4739 holding.
  • Barclays first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2022 and has held it in 17 quarters since.
  • Barclays's AdvisorShares Pure US Cannabis ETF position peaked at $1.91M in Q1 2022.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.